Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06385223

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression: a Double Blind, Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Institute of Mental Health, Singapore · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The Investigators propose to carry out a randomized, double-blind trial to compare the clinical efficacy of an individualized connectome-guided accelerated iTBS vs an anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients and outpatients who had been referred for TMS for the treatment of depression.

Conditions

Interventions

TypeNameDescription
DEVICEBeam F3 targeted accelerated iTBSMagpro X100, Axilium Cobot, Localite camera
DEVICEIndividualized connectome-guided accelerated iTBSMagpro X100, Axilium Cobot, Localite camera

Timeline

Start date
2024-07-01
Primary completion
2026-07-01
Completion
2026-12-31
First posted
2024-04-25
Last updated
2024-08-01

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06385223. Inclusion in this directory is not an endorsement.

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression (NCT06385223) · Clinical Trials Directory